Introduction
Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges.
Reasons to Purchase
*Review the clinical and commercial factors driving new product decisions in influenza vaccines and the strategies of key players in the market
*Size the market with patient-based scenario forecasts of the seasonal vaccines market and a thorough analysis of the vaccine and antiviral pipeline
*Understand concerns, unmet needs and future opportunities in influenza prevention and therapy
Other selected research from the 'Markets' category:
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
Obesity Market Forecast
Other selected research from the 'Vaccines' category:
Cancer Vaccines Fantasy or Future?
Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness
